N. Pomara

J. Sidtis, N. Pomara, P. Mehta, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2019, Nature Communications.

Instrumental activities of daily living in the screening of dementia in population studies--response to comments by Sikkes et al.

J. Sidtis, N. Pomara, 2007 .

18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

David T. Jones, Keith A. Johnson, Jeffrey N. Browndyke, 2018, Anesthesiology.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2020, Nature Communications.

Is there a relationship between morphological and functional platelet changes and depressive disorder?

N. Pomara, D. Marazziti, M. G. Carbone, 2020, CNS Spectrums.

A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Communications Medicine.

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, GeroScience.

Does increased platelet release of Abeta peptide contribute to brain abnormalities in individuals with depression?

N. Pomara, P. Murali Doraiswamy, 2003, Medical hypotheses.

Effects of Antidepressants on Human Performance: A Review

N. Pomara, D. Deptula, 1990, Journal of clinical psychopharmacology.

Proline in the cerebrospinal fluid of normal subjects and Alzheimer's-disease patients, as determined with a new double-labeling assay technique.

N. Pomara, S. Brinkman, R. Baldwin, 1984, Biochemical medicine.

Lower plasma β-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementia

N. Pomara, D. Bruno, 2011, Evidence Based Mental Health.

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

CSF GABA in caregiver spouses of Alzheimer patients.

N. Pomara, M. Galloway, M. Stanley, 1989, The American journal of psychiatry.

Memory performance in individuals with primary degenerative dementia: its similarity to diazepam-induced impairments.

N. Pomara, M. Stanley, B. Stanley, 1985, Experimental aging research.

Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease.

G. Mashour, N. Pomara, D. Loeffler, 1994, Alzheimer disease and associated disorders.

Pathological Increases in Neuronal Hyperactivity in Selective Cholinergic and Noradrenergic Pathways May Limit the Efficacy of Amyloid-β-Based Interventions in Mild Cognitive Impairment and Alzheimer’s Disease

N. Pomara, D. Bruno, 2018, Journal of Alzheimer's disease reports.

Increased CSF HVA response to arecoline challenge in Alzheimer's disease

N. Pomara, M. Galloway, M. Stanley, 2005, Journal of Neural Transmission / General Section JNT.

The Effect of Mifepristone (RU 486) on Plasma Cortisol in Alzheimer’s Disease

J. Sidtis, T. Cooper, N. Pomara, 2006, Neurochemical Research.

Comparison of methods for analysis of CSF proteins in patients with Alzheimer's disease.

N. Pomara, J. Weintraub, J. Gilroy, 1987, Neurochemical pathology.

Prospective strategies for cholinergic interventions in Alzheimer's disease

N. Pomara, M. Stanley, G. Yarbrough, 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown.

N. Pomara, W. Mack, B. Zlokovic, 2013, JAMA neurology.

Decreases in Plasma Aβ1-40 Levels with Aging in Non-Demented Elderly with ApoE-ε4 Allele

N. Pomara, T. Wisniewski, P. Mehta, 1998, Neurochemical Research.

Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.

K. Blennow, J. Sidtis, J. Nierenberg, 2012, The American journal of psychiatry.

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Scientific Reports.

Plasma beta-amyloid level, cognitive reserve, and cognitive decline.

J. Sidtis, N. Pomara, D. Bruno, 2011, JAMA.

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study

Chelsea Reichert Plaska, K. Blennow, N. Pomara, 2022, Translational Psychiatry.

Aging and cortisol resistance to suppression by dexamethasone: A positive correlation

Iain M McIntyre, N. Pomara, G. Oxenkrug, 1983, Psychiatry Research.

Prediction of serum cortisol response to dexamethasone in normal volunteers: A multivariate approach

Iain M McIntyre, N. Pomara, G. Oxenkrug, 2004, Psychopharmacology.

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease

N. Pomara, S. Gershon, M. Stanley, 1985, Neurobiology of Aging.

Lithium treatment in Alzheimer’s disease does not promote cognitive enhancement, but may exert long-term neuroprotective effects

N. Pomara, 2009, Psychopharmacology.

Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder

J. Sidtis, D. Greenblatt, T. Cooper, 2005, Psychopharmacology.

Alterations in cholinergic receptors mediate the effects of dexamethasone on corticosterone

Iain M McIntyre, N. Pomara, G. Oxenkrug, 1985, Biological Psychiatry.

Unproved Modality in the Treatment of Alzheimer‐Type Dementia

N. Pomara, M. Russell, M. Cardelli, 1985 .

Chelation therapy. Unproved modality in the treatment of Alzheimer-type dementia.

N. Pomara, M. Russell, M. Cardelli, 1985, Journal of the American Geriatrics Society.

White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study

Glyn Johnson, Kelvin O. Lim, Nunzio Pomara, 2001, Psychiatry Research: Neuroimaging.

A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).

N. Pomara, N. Barnett, P. Goodnick, 1982, Journal of clinical psychopharmacology.

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

Keith A. Johnson, Raymond Scott Turner, Joanne L. Lord, 2021, Scientific Reports.

Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau

Sterling C. Johnson, Nick C Fox, John X. Morris, 2020, Brain communications.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2016, Scientific Reports.

Output order and variability in free recall are linked to cognitive ability and hippocampal volume in elderly individuals

J. Sidtis, J. Nierenberg, S. Teipel, 2016, Neuropsychologia.

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Keith A. Johnson, Joanne L. Lord, Colleen S. Albers, 2016, Molecular Neurobiology.

Aging, emotional states, and memory.

N. Pomara, D. Deptula, N Pomara, 1993, The American journal of psychiatry.

Mifepristone (RU 486) for Alzheimer's disease.

P. Doraiswamy, N. Pomara, S. Ferris, 2002, Neurology.

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

Steven G Potkin, Nunzio Pomara, Brian R Ott, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Glutamate and other CSF amino acids in Alzheimer's disease.

N. Pomara, D. Deptula, N Pomara, 1992, The American journal of psychiatry.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

Sterling C. Johnson, David T. Jones, Taylor W. Schmitz, 2016, Nature Communications.

Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE

Keith A. Johnson, Scott Ayton, Joanne L. Lord, 2015, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Adverse performance effects of acute lorazepam administration in elderly long-term users: Pharmacokinetic and clinical predictors

J. Sidtis, Sang Han Lee, E. Petkova, 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

CSF butyrylcholinesterase and acetylcholinesterase activity and their relationship to pro-inflammatory cytokines in late-life major depression

K. Blennow, J. Nierenberg, N. Pomara, 2019, European Neuropsychopharmacology.

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Sterling C. Johnson, Christine L. Tardif, John X. Morris, 2021, Nature Communications.

A review of the relationship between proinflammatory cytokines and major depressive disorder.

N. Pomara, D. Bruno, J. Young, 2014, Journal of affective disorders.

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores

Mark T. W. Ebbert, Raymond Scott Turner, Owen Carmichael, 2021, Communications Biology.

Non-coding variability at the APOE locus contributes to the Alzheimer’s risk

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2019, Nature Communications.

Four distinct trajectories of tau deposition identified in Alzheimer’s disease

Sterling C. Johnson, John X. Morris, Keith A. Johnson, 2021, Nature Medicine.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

Michael W. Weiner, Robert C. Green, Shannon L. Risacher, 2017, Scientific Reports.

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

Keith A. Johnson, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Andrew J. Saykin, Arthur W. Toga, Qianjin Feng, 2017, Scientific Reports.

Type 2 Diabetes Mellitus, Platelet Activation and Alzheimer’s Disease: A Possible Connection

N. Pomara, C. Callegari, D. Marazziti, 2022, Clinical neuropsychiatry.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer’s Disease? A Systematic Review

N. Pomara, D. Marazziti, M. G. Carbone, 2021, Life.

Pathophysiology of Alzheimer's disease.

N. Pomara, B. Imbimbo, J. Lombard, 2005, Neuroimaging clinics of North America.

Increased sensitivity of the elderly to the central depressant effects of diazepam.

D. Greenblatt, N. Pomara, S. Gershon, 1985, The Journal of clinical psychiatry.

Electrophoresis and immunoblot of cerebrospinal fluid proteins in spasmodic torticollis

N. Pomara, P. Cullis, P. LeWitt, 1986, Movement disorders : official journal of the Movement Disorder Society.

Plasma BDNF Levels Vary in Relation to Body Weight in Females

K. Blennow, J. Nierenberg, L. Saint-Louis, 2012, PloS one.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Keith A. Johnson, Charles D. Smith, Sherye A. Sirrel, 2020, Nature Communications.

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2021, Translational Psychiatry.

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

Basal forebrain mediated increase in brain CRF is associated with increased cholinergic tone and depression

B. Pollock, C. Marmar, J. Nierenberg, 2017, Psychiatry Research: Neuroimaging.

Baseline Plasma GABA: Its Relationship to the Adverse Effects of Acute Lorazepam Administration on Cognition in the Elderly

J. Sidtis, P. Doraiswamy, D. Greenblatt, 2004, Neurochemical Research.

Clinical Ratings: Relationship to Objective Psychometric Assessment in Individuals with Dementia

N. Pomara, R. Block, M. Russell, 1985, Psychological reports.

Interdose Elevation in Plasma Cortisol During Chronic Treatment with Alprazolam but not Lorazepam in the Elderly

J. Sidtis, C. Nemeroff, D. Greenblatt, 2004, Neuropsychopharmacology.

Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants

J. Nierenberg, N. Pomara, J. Ritchie, 2012, Psychoneuroendocrinology.

Immunocytochemical Detection of Anti-Hippocampal Antibodies in Alzheimer's Disease and Normal Cerebrospinal Fluid

N. Pomara, D. Loeffler, P. Juneau, 1997, Neurochemical Research.

J. Sidtis, C. Nemeroff, D. Greenblatt, 2005, Psychopharmacology.

Loss of the cortisol response to naltrexone in Alzheimer's disease

C. Tamminga, N. Pomara, M. Galloway, 1988, Biological Psychiatry.

Elevation in Plasma Abeta42 in Geriatric Depression: A Pilot Study

B. Pollock, B. Mulsant, C. Reynolds, 2006, Neurochemical Research.

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: Its relationship to severity of dementia and monoamine metabolites

C. Nemeroff, N. Pomara, M. Stanley, 1989, Biological Psychiatry.

Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression.

Chelsea Reichert Plaska, K. Blennow, N. Pomara, 2021, Journal of affective disorders.

Soluble amyloid-β levels and late-life depression.

N. Pomara, R. Osorio, T. Gumb, 2014, Current pharmaceutical design.

Increased Anticholinergic Challenge-Induced Memory Impairment Associated with the APOE-ɛ4 Allele in the Elderly: A Controlled Pilot Study

J. Sidtis, N. Pomara, K. Wesnes, 2004, Neuropsychopharmacology.

Decreased recall of primacy words predicts cognitive decline.

J. Sidtis, P. Reiss, E. Petkova, 2013, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

Does severity of dementia modulate response to dexamethasone in individuals with primary degenerative dementia?

Iain M McIntyre, N. Pomara, G. Oxenkrug, 1984, Biological psychiatry.

Nobel prize for literature

N. Pomara, 1996, The Lancet.

The recency ratio as an index of cognitive performance and decline in elderly individuals

N. Pomara, D. Bruno, C. Reichert, 2016, Journal of clinical and experimental neuropsychology.

Neuronal correlates of serial position performance in amnestic mild cognitive impairment.

M. Ewers, S. Teipel, N. Pomara, 2016, Neuropsychology.

The trend of disruption in the functional brain network topology of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Scientific Reports.

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images

Adrian Preda, Evan Fletcher, Godfrey Pearlson, 2018, Scientific Reports.

Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2022, GeroScience.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2018, Molecular Neurobiology.

The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals.

K. Blennow, J. Nierenberg, S. Teipel, 2016 .

The relationship between cerebrospinal fluid tau markers, hippocampal volume, and delayed primacy performance in cognitively intact elderly individuals

K. Blennow, J. Nierenberg, S. Teipel, 2015, Alzheimer's & dementia.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Major Depression May Lead to Elevations in Potentially Neurotoxic Amyloid Beta Species Independently of Alzheimer Disease.

N. Pomara, D. Bruno, 2016, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Is there Progress ? An Overview of Select Biomarker Candidates for 1 Major Depressive Disorder 2

C. Marmar, N. Pomara, I. Galatzer-Levy, 2018 .

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder

C. Marmar, N. Pomara, I. Galatzer-Levy, 2016, Front. Psychiatry.

Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2023, Communications Medicine.

Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

K. Hashimoto, C. Marmar, K. Blennow, 2016, Translational Psychiatry.

Scopolamine-induced impariment as a potential predictor of Alzheimer's Disease in individuals with Apolipoprotein E type 4 alleles

N. Pomara, K. Nolan, Glenn Halpern, 1995, Neurochemical Research.

Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration

J. Sidtis, D. Greenblatt, N. Pomara, 2006, Psychopharmacology.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2019, Scientific Reports.

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2021, Translational Psychiatry.

Memantine Treatment of Cognitive Symptoms in Mild to Moderate Alzheimer Disease: Secondary Analyses From a Placebo-controlled Randomized Trial

N. Pomara, E. Peskind, B. Ott, 2007, Alzheimer disease and associated disorders.

Milacemide: A Placebo‐Controlled Study in Senile Dementia of the Alzheimer Type

J. Mendels, B. Reisberg, N. Pomara, 1992, Journal of the American Geriatrics Society.

CSF α-synuclein correlates with CSF neurogranin in late-life depression

K. Blennow, N. Pomara, H. Zetterberg, 2020, The International journal of neuroscience.

CSF alpha synuclein and late-life depression CSF alpha synuclein correlates with CSF neurogranin in late-life depression

K. Blennow, N. Pomara, H. Zetterberg, 2020 .

Does cortical thinning in persons at increased risk for major depression also increase their risk for Alzheimer's disease?

J. Sidtis, N. Pomara, 2009, Proceedings of the National Academy of Sciences.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Keith A. Johnson, Raymond Scott Turner, Charles D. Smith, 2022, Nature Aging.

Retrograde facilitation of verbal memory by trihexyphenidyl in healthy elderly with and without the APOE ε4 allele

J. Sidtis, Kenneth D. Belzer, N. Pomara, 2010, European Neuropsychopharmacology.

Increased mental slowing associated with the APOE epsilon4 allele after trihexyphenidyl oral anticholinergic challenge in healthy elderly.

J. Sidtis, Kenneth D. Belzer, N. Pomara, 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Hippocampus and basal forebrain volumes modulate effects of anticholinergic treatment on delayed recall in healthy older adults

J. Nierenberg, S. Teipel, N. Pomara, 2015, Alzheimer's & dementia.

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features

Adrian Preda, Evan Fletcher, Charles DeCarli, 2017, Scientific Reports.

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states

Islem Rekik, Mohamed Ali Mahjoub, Keith A. Johnson, 2018, Scientific Reports.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019, Nature Communications.

Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder

K. Blennow, J. Nierenberg, N. Pomara, 2019, Biomarkers in neuropsychiatry.

Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants

Michael W. Lutz, Davide Bruno, Henrik Zetterberg, 2012, Experimental Gerontology.

Attenuation of pilocarpine-induced hypothermia in response to chronic administration of choline

N. Pomara, S. Gershon, M. Stanley, 2004, Psychopharmacology.

CHOLINERGIC PRECURSORS IN ALZHEIMER'S DISEASE

N. Pomara, M. Stanley, 1982, The Lancet.

Monoamine neurotransmitter metabolites and hydroxylase Cofactor in alzheimer-type dementia and normals

R. Levine, N. Pomara, M. Stanley, 1986 .

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Keith A. Johnson, Michael W. Paul Ronald Clifford R. Andrew J. William John Weiner Aisen Petersen Jack Saykin Jagust , Sherye A. Sirrel, 2019, Scientific Reports.

Brain neurotoxic amyloid‐beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets

J. Sidtis, N. Pomara, 2010, British journal of pharmacology.

A review of the relationship between proin- flammatory Cytokines and major depressive disorder

N. Pomara, D. Bruno, J. Young, 2019 .

Cognitive Reserve and Emotional Stimuli in Older Individuals: Level of Education Moderates the Age-Related Positivity Effect

C. Marmar, N. Pomara, Aycan Kapucu, 2014, Experimental aging research.

The recency ratio is associated with reduced CSF glutamate in late-life depression

K. Hashimoto, C. Marmar, K. Blennow, 2017, Neurobiology of Learning and Memory.

State-dependent alterations in cerebrospinal fluid A&bgr;42 levels in cognitively intact elderly with late-life major depression

C. Marmar, K. Blennow, J. Nierenberg, 2016, NeuroReport.

The recency ratio as predictor of early MCI

N. Pomara, R. Koscik, J. Woodard, 2018, International Psychogeriatrics.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

György J. Simon, David T. Jones, Keith A. Johnson, 2020, Scientific Reports.

Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study

K. Hashimoto, C. Marmar, K. Blennow, 2017, Scientific Reports.

Recency ratio and early MCI Corresponding

N. Pomara, R. Koscik, J. Woodard, 2019 .

Efficacy and safety of vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial.

N. Pomara, H. Croft, C. Gommoll, 2014, The Journal of clinical psychiatry.

Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer’s disease?

N. Pomara, B. Imbimbo, M. G. Carbone, 2021, Ageing Research Reviews.

Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

The apolipoprotein E ɛ4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge

John J. Sidtis, Nunzio Pomara, J. Sidtis, 2008, Psychopharmacology.

ApoE-epsilon 4 allele and susceptibility to drug-induced memory impairment in the elderly.

D. Greenblatt, N. Pomara, D. Deptula, 1998, Journal of clinical psychopharmacology.

Drug-induced reductions in brain amyloid-β levels may adversely affect cognition and behavior by a disruption of functional connectivity homeostasis.

N. Pomara, B. Imbimbo, 2019, Neurodegenerative disease management.

Risperidone in the treatment of elderly patients with psychotic disorders.

N. Pomara, M. Brecher, M. Kunik, 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

TOMM40 poly-T Variants and Cerebrospinal Fluid Amyloid Beta Levels in the Elderly

K. Blennow, J. Sidtis, J. Nierenberg, 2011, Neurochemical Research.

A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Sherye A. Sirrel, 2020, Scientific Reports.

Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers

John J Sidtis, Nunzio Pomara, Matthew J Hoptman, 2005, Neuroreport.

Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.

M. Munk, F. Jessen, J. Haynes, 2021, Journal of Alzheimer's disease : JAD.

Effects of diazepam on recall memory: relationship to aging, dose, and duration of treatment.

D. Greenblatt, N. Pomara, M. Medel, 1989, Psychopharmacology bulletin.

Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly.

A. Roses, J. Sidtis, D. Greenblatt, 2011, Journal of clinical psychopharmacology.

Benzodiazepine use and crash risk in older patients.

D. Greenblatt, N. Pomara, D. Deptula, 1998, JAMA.

Equivalence of Five Forms of the Selective Reminding Test in Young and Elderly Subjects

R. Block, N. Pomara, D. Deptula, 1990, Psychological reports.

Lithium-induced increases in red blood cell choline and memory performance in Alzheimer-type dementia.

N. Pomara, N. Barnett, S. Brinkman, 1984, Biological psychiatry.

Elevation of RBC glycine and choline levels in geriatric patients treated with lithium.

N. Pomara, S. Gershon, M. Stanley, 1983, The American journal of psychiatry.

Lithium, memory and RBC/plasma choline in Alzheimer-type dementia

N. Pomara, S. Brinkman, E. Domino, 1982 .

HIPPOCAMPAL SIZE PREDICTS DELAYED PRIMACY PERFORMANCE IN COGNITIVELY INTACT ELDERLY PARTICIPANTS

J. Nierenberg, S. Teipel, N. Pomara, 2014, Alzheimer's & Dementia.

Treatment-resistant depression in an elderly patient with pancreatic carcinoma: case report.

N. Pomara, S. Gershon, 1984, The Journal of clinical psychiatry.

Different Sides of Depression in the Elderly: An In-depth View on the Role of Aβ Peptides.

N. Pomara, D. Marazziti, B. Imbimbo, 2021, Current medicinal chemistry.

Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update.

P. Doraiswamy, N. Pomara, W. Greenberg, 2003, Psychopharmacology bulletin.

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images

Sterling C. Johnson, Mirza Faisal Beg, Karteek Popuri, 2017, ArXiv.

Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: Relationship to plasma concentrations

D. Greenblatt, N. Pomara, S. Gershon, 2004, Psychopharmacology.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2018, Anesthesiology.

Apolipoprotein E ɛ4 and Anticholinergic Cognitive Toxicity

J. Sidtis, N. Pomara, 2009, Journal of The American Geriatrics Society.

A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer's disease.

K. Blennow, O. Okonkwo, N. Pomara, 2023, Journal of Clinical and Experimental Neuropsychology.

Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.

J. Sidtis, D. Greenblatt, N. Pomara, 2005, Archives of general psychiatry.

Cross-sectional associations of CSF tau levels with Rey's AVLT: A recency ratio study.

K. Blennow, O. Okonkwo, N. Pomara, 2022, Neuropsychology.

Semagacestat for treatment of Alzheimer's disease.

N. Pomara, 2013, The New England journal of medicine.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Pathophysiology of Alzheimer's disease.

N. Pomara, B. Imbimbo, J. Lombard, 2005, Neuroimaging clinics of North America.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

Russell's revised Wechsler Memory Scale in the evaluation of dementia.

N. Pomara, S. Brinkman, S. Gerganoff, 1983, Journal of clinical psychology.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

David T. Jones, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Brain Amyloid Deposition in Late-Life Depression

N. Pomara, B. Imbimbo, 2020, Biological Psychiatry.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

GenEpi: gene-based epistasis discovery using machine learning

Michael W. Weiner, Yen-Jen Oyang, Arthur W. Toga, 2018, BMC Bioinformatics.

Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder.

Chelsea Reichert Plaska, K. Blennow, S. Teipel, 2021, Journal of affective disorders.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2018, Scientific Reports.

O1-05-04 Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: a randomized controlled trial

S. Potkin, N. Pomara, E. Peskind, 2004, Neurobiology of Aging.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Sterling C. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2023, BMC Geriatrics.

A review of the relationship between proinflammatory cytokines and major depressive disorder.

N. Pomara, D. Bruno, J. Young, 2014, Journal of affective disorders.

The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.

D. Greenblatt, N. Pomara, D. Deptula, 1998, Psychopharmacology bulletin.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Sterling C. Johnson, Sherye A. Sirrel, Alice D. Brown, 2015, Nature Communications.

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline

A. Spottke, E. Düzel, N. Pomara, 2024, Alzheimer's & dementia.

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2024, Alzheimer's research & therapy.

Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophrenia.

N. Pomara, 2009, The American journal of psychiatry.

Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

K. Hashimoto, C. Marmar, K. Blennow, 2016, Translational Psychiatry.

Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer’s disease

N. Pomara, M. Grothe, M. Dyrba, 2024, Scientific reports.

Does cortical thinning in persons at increased risk for major depression also increase their risk for Alzheimer's disease?

J. Sidtis, N. Pomara, 2009, Proceedings of the National Academy of Sciences.

Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19

N. Pomara, B. Imbimbo, 2020, Medical Hypotheses.

Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study

K. Hashimoto, C. Marmar, K. Blennow, 2017, Scientific Reports.

The recency ratio is related to CSF amyloid beta 1‐42 levels in MCI‐AD

Sterling C. Johnson, K. Blennow, N. Pomara, 2018, International journal of geriatric psychiatry.

Recency ratio and ABeta42 The recency ratio is related to CSF Amyloid Beta 1-42 levels in MCI

Sterling C. Johnson, K. Blennow, N. Pomara, 2018 .

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Sterling C. Johnson, David T. Jones, Nick C Fox, 2017, Scientific Reports.